PUBLIC EVIDENCE LAB

Inspect Timory's source links, recurrence rules and explicit unknowns. Have an internal positioning decision? The private Sprint uses a separate evidence boundary.

See the private Research Sprint →

Name a market. We will look for recurring, source-linked evidence—not tell you what to build.

LAST COLLECTION <1h ago7943 SIGNALS8 FEEDS580 PAYMENT-EVIDENCE SIGNALS
#DossierEvidence levelRecurrenceRecency
1281 Opportunity dossier O-0715 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1282 Opportunity dossier O-0697 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1283 Opportunity dossier O-0695 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1284 Opportunity dossier O-0677 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1285 Opportunity dossier O-0669 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1286 Opportunity dossier O-0663 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1287 Opportunity dossier O-0657 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1288 Opportunity dossier O-0656 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1289 Opportunity dossier O-0651 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1290 Opportunity dossier O-0643 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1291 Opportunity dossier O-0623 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1292 Opportunity dossier O-0612 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1293 Opportunity dossier O-2499 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1294 Opportunity dossier O-1887 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1295 Opportunity dossier O-1667 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1296 Opportunity dossier O-1440 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1297 Opportunity dossier O-0986 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1298 Opportunity dossier O-0763 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1299 Opportunity dossier O-0726 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02 1300 Opportunity dossier O-0681 Recurring need documented in 1 independent public source item. English editorial summary pending; source evidence remains available. Evidence levelSignal1 item · 1 source 12-week activity Recency Fading · 2026-09-02

Public dossiers offer free email unlock for the full evidence chain. Free Market Watch is self-serve: name a niche, preview matching dossiers and save change alerts over Timory's shared corpus.